Abstract: Asphalt binders and methods for making and using same. In at least one specific embodiment, the asphalt binder can include a bitumen and a glyceride and fatty acid mixture. The glyceride and fatty acid mixture can include one or more triglycerides, at least 1 wt % of one or more diglycerides, and at least 5 wt % of one or more fatty acids, based on the combined weight of the one or more triglycerides, the one or more diglycerides, and the one or more fatty acids. The asphalt binder can be made by combining a bitumen and a glyceride and fatty acid mixture. A paving composition can be made by combining a plurality of solids and the asphalt binder. A road can include a plurality of solids mixed with the asphalt binder.

Abstract: A system for sealing components of an exhaust system in an engine system comprises a bellows with an elongated portion. A flange is coupled to the elongated portion, the flange comprising a first portion and a second portion. An extended portion extends between the first portion and the second portion, the extended portion defining a gap and having a cross-sectional shape different than the first portion and the second portion. A connector is configured to couple an aftertreatment system to the flange. The connector comprises a sealing surface adjacent to the flange. A sealing component is sized and configured to fit partially within the gap and contact the sealing surface to create a seal between the extended portion and the sealing surface.

Abstract: A system for sealing components of an exhaust system in an engine system comprises a bellows with an elongated portion. A flange is coupled to the elongated portion, the flange comprising a first portion and a second portion. An extended portion extends between the first portion and the second portion, the extended portion defining a gap and having a cross-sectional shape different than the first portion and the second portion. A connector is configured to couple an aftertreatment system to the flange. The connector comprises a sealing surface adjacent to the flange. A sealing component is sized and configured to fit partially within the gap and contact the sealing surface to create a seal between the extended portion and the sealing surface.

Abstract: Asphalt binders and methods for making and using same. In at least one specific embodiment, the asphalt binder can include a bitumen and a glyceride and fatty acid mixture. The glyceride and fatty acid mixture can include one or more triglycerides, at least 1 wt % of one or more diglycerides, and at least 5 wt % of one or more fatty acids, based on the combined weight of the one or more triglycerides, the one or more diglycerides, and the one or more fatty acids. The asphalt binder can be made by combining a bitumen and a glyceride and fatty acid mixture. A paving composition can be made by combining a plurality of solids and the asphalt binder. A road can include a plurality of solids mixed with the asphalt binder.

Abstract: Asphalt binders and methods for making and using same. In at least one specific embodiment, the asphalt binder can include a bitumen and a glyceride and fatty acid mixture. The glyceride and fatty acid mixture can include one or more triglycerides, at least 1 wt % of one or more diglycerides, and at least 5 wt % of one or more fatty acids, based on the combined weight of the one or more triglycerides, the one or more diglycerides, and the one or more fatty acids. The asphalt binder can be made by combining a bitumen and a glyceride and fatty acid mixture. A paving composition can be made by combining a plurality of solids and the asphalt binder. A road can include a plurality of solids mixed with the asphalt binder.

Abstract: Edible compositions are provided and comprise a soluble mineral component and/or a phosphate component in amounts effective for use as an oral medicament. The soluble mineral component comprises one or more minerals selected from the group consisting of zinc, manganese, tin, copper, and mixtures thereof. The edible compositions are advantageously companion animal chews, treats or supplements. Further disclosed are methods of making the chews, treats or supplements as are methods of treating conditions of the oral cavity.

Abstract: Disclosed herein are a variety of embodiments of compositions and methods which are each adapted for use by a companion animal. In one embodiment, an edible composition comprising an amount of a soluble mineral component is disclosed, wherein the soluble mineral component comprises one or more minerals selected from the group consisting of zinc, manganese, tin, copper, and mixtures thereof, wherein the amount is an effective amount for use as an oral medicament. In further embodiments, a phosphate component is included. The edible compositions are advantageously companion animal foods or supplements. Further disclosed are methods selected from treating oral cavity tartar, oral cavity plaque, periodontal disease, gingivitis, breath odor and combinations thereof comprising orally administering a described composition to a companion animal.

Abstract: A functional fluid useful as an emulsion in a cleaning product or a personal care product is the esterification reaction product of a) a triglyceride or a fatty acid or a methyl ester of a fatty acid, and b) an alcohol which comprises b1) a polyglycerol having at least 3 glycerol units (preferably polyglycerol-4), and b2) glycerol and/or diglycerol. The functional fluid is effective as a stabilizer and as an emulsifier for o/w and w/o emulsions. When a triglyceride is used as a reactant, glycerol and fatty acids are generated in situ by an interesterification reaction. Preferred functional fluids provide the significant benefit that they may be mixed into an oil phase and in a water phase before such phases are mixed together, and that such processing may be carried out at ambient temperature.

Abstract: Asphalt binders and methods for making and using same. In at least one specific embodiment, the asphalt binder can include a bitumen and a glyceride and fatty acid mixture. The glyceride and fatty acid mixture can include one or more triglycerides, at least 1 wt % of one or more diglycerides, and at least 5 wt % of one or more fatty acids, based on the combined weight of the one or more triglycerides, the one or more diglycerides, and the one or more fatty acids. The asphalt binder can be made by combining a bitumen and a glyceride and fatty acid mixture. A paving composition can be made by combining a plurality of solids and the asphalt binder. A road can include a plurality of solids mixed with the asphalt binder.

Abstract: Asphalt binders and methods for making and using same. In at least one specific embodiment, the asphalt binder can include a bitumen and a glyceride and fatty acid mixture. The glyceride and fatty acid mixture can include one or more triglycerides, at least 1 wt % of one or more diglycerides, and at least 5 wt % of one or more fatty acids, based on the combined weight of the one or more triglycerides, the one or more diglycerides, and the one or more fatty acids. The asphalt binder can be made by combining a bitumen and a glyceride and fatty acid mixture. A paving composition can be made by combining a plurality of solids and the asphalt binder. A road can include a plurality of solids mixed with the asphalt binder.

Abstract: A foled (flexible organic light emitting diode) display cap is disclosed. The foled display cap provides a wearable hat comprising an integrated housing for attaching and operating a miniaturized foled video screen. The integrated housing further includes a software module having a memory module and a plurality of buttons for controlling images which are visible on its screen. In use, a wearer of the cap may input through use of the buttons digital representations of video, images, or text and store these digital representations into the memory module for use by the software module through a USB input port within the integrated housing. An electrical power source which may be by way of example a thin film polymer rechargeable battery is also located within the integrated housing for supplying electrical power to the miniaturized foled video screen and software/memory module while also providing a means for recharging the battery.

Abstract: Asphalt binders and methods for making and using same. In at least one specific embodiment, the asphalt binder can include a bitumen and a glyceride and fatty acid mixture. The glyceride and fatty acid mixture can include one or more triglycerides, at least 1 wt % of one or more diglycerides, and at least 5 wt % of one or more fatty acids, based on the combined weight of the one or more triglycerides, the one or more diglycerides, and the one or more fatty acids. The asphalt binder can be made by combining a bitumen and a glyceride and fatty acid mixture. A paving composition can be made by combining a plurality of solids and the asphalt binder. A road can include a plurality of solids mixed with the asphalt binder.

Abstract: A functional fluid useful as an emulsion in a cleaning product or a personal care product is the esterification reaction product of a) a triglyceride or a fatty acid or a methyl ester of a fatty acid, and b) an alcohol which comprises b1) a polyglycerol having at least 3 glycerol units (preferably polyglycerol-4), and b2) glycerol and/or diglycerol. The functional fluid is effective as a stabiliser and as an emulsifier for o/w and w/o emulsions. When a triglyceride is used as a reactant, glycerol and fatty acids are generated in situ by an interesterification reaction. Preferred functional fluids provide the significant benefit that they may be mixed into an oil phase and in a water phase before such phases are mixed together, and that such processing may be carried out at ambient temperature.

Abstract: A pet food composition comprising a supplement is provided. The supplement can comprise a Probiotic component, a cocoa butter component, and a sweetener component. A process for making the supplement can comprise providing a sweetener component, a cocoa butter component, and a Probiotic component, mixing the cocoa butter component and Probiotic component to form a mixture in a temperature and humidity controlled chamber; mixing the mixture with the sweetener component in the temperature and humidity controlled chamber to form a final mixture; optionally mixing in a colorant with the final mixture; and cooling the final mixture. A package for the supplement can comprise a secondary container housing a primary container, which houses a supplement. An array of packages is also provided.

Abstract: An individually-packaged shelf-stable snack-sized pet food mix. The pet food mix includes at least two visually identifiable dried ingredients, wherein a total amount of about 5 grams to about 25 grams of the pet food mix is contained within the individual package and provides less than about 25% of the daily calories of the pet.

Abstract: The present invention relates to an artificially carbonated beverage containing a foam control agent and/or carbon dioxide control agent, the control agent comprising a polyglycerol fatty acid ester. A sealed container containing such a beverage, a concentrate for such a beverage, a method of making such a beverage and a method of reducing foaming and/or improving retention of carbon dioxide in such a beverage, are also described.

Abstract: Embodiments of the present invention provides systems, methods, and computer-readable media for distributing a specialty drug, such as an omega conopeptide, using a computer hub that facilitates reimbursement assistance, higher expertise in handling, better care of the product, and reduced patient cost. For example, responsive to a prescription, if the patient is currently enrolled in a commercial insurance plan, a patient out-of-pocket requirement can be compared to a capped payment amount. If the patient out-of-pocket requirement exceeds the capped payment amount, a total invoice amount of the specialty drug can be divided by a total invoice amount of the prescription to obtain a percentage of the total invoice attributable to the specialty drug, that percentage multiplied by the patient out-of-pocket requirement to obtain an initial patient obligation for only the specialty drug, and the initial patient obligation for only the specialty drug reduced to the capped payment amount.